GB201407693D0 - Compound - Google Patents

Compound

Info

Publication number
GB201407693D0
GB201407693D0 GBGB1407693.9A GB201407693A GB201407693D0 GB 201407693 D0 GB201407693 D0 GB 201407693D0 GB 201407693 A GB201407693 A GB 201407693A GB 201407693 D0 GB201407693 D0 GB 201407693D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1407693.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
De Montfort University
Original Assignee
De Montfort University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by De Montfort University filed Critical De Montfort University
Priority to GBGB1407693.9A priority Critical patent/GB201407693D0/en
Publication of GB201407693D0 publication Critical patent/GB201407693D0/en
Priority to PCT/EP2015/059500 priority patent/WO2015166040A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
GBGB1407693.9A 2014-05-01 2014-05-01 Compound Ceased GB201407693D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1407693.9A GB201407693D0 (en) 2014-05-01 2014-05-01 Compound
PCT/EP2015/059500 WO2015166040A2 (en) 2014-05-01 2015-04-30 Compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1407693.9A GB201407693D0 (en) 2014-05-01 2014-05-01 Compound

Publications (1)

Publication Number Publication Date
GB201407693D0 true GB201407693D0 (en) 2014-06-18

Family

ID=50980424

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1407693.9A Ceased GB201407693D0 (en) 2014-05-01 2014-05-01 Compound

Country Status (2)

Country Link
GB (1) GB201407693D0 (en)
WO (1) WO2015166040A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109535068B (en) * 2018-12-26 2022-07-29 中国药科大学 Pyridine substituted chalcone compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096753A (en) * 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
KR100934706B1 (en) * 2006-12-07 2009-12-31 재단법인서울대학교산학협력재단 Method for Screening Anti-cancer Compounds Inhibiting Functions of TM4SF5 and Anti-cancer Composition Containing Chalcone Compounds
JP2010531304A (en) * 2007-06-18 2010-09-24 ユニバーシティ オブ ルイビル リサーチ ファウンデーション、インコーポレイテッド PFKFB3 inhibitor family with antineoplastic activity
WO2013054998A1 (en) * 2011-10-13 2013-04-18 건국대학교 산학협력단 Novel chalcone derivative and anticancer composition comprising same as active ingredient

Also Published As

Publication number Publication date
WO2015166040A2 (en) 2015-11-05
WO2015166040A3 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
GB201417002D0 (en) Novel compound
GB201415573D0 (en) Compounds
GB201418300D0 (en) Compounds
GB201411418D0 (en) Compounds
GB201410430D0 (en) Compounds
GB201402431D0 (en) Compounds
GB201417369D0 (en) Compounds
GB201404987D0 (en) Compounds
GB201417561D0 (en) Compounds
GB201416186D0 (en) Compounds
GB201406591D0 (en) Compounds
GB201419228D0 (en) Compounds
GB201406956D0 (en) Compounds
AP2017009778A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201419264D0 (en) Compounds
GB201413695D0 (en) Compound
GB201412238D0 (en) Compound
GB201412660D0 (en) Compounds
GB201417168D0 (en) Compounds
GB201407694D0 (en) Compound
GB201419015D0 (en) Compounds
GB201407506D0 (en) Novel compound
GB201407695D0 (en) Compounds
GB201418709D0 (en) Compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)